8.9 C
New York
Thursday, April 18, 2024
HomeMarkets
Markets

10 Biggest Price Target Changes For Monday

By Insider Scoop
1
104
psw-placeholder
psw-placeholder

Courtesy of Benzinga

  • Argus Research boosted the price target for Eli Lilly And Co (NYSE: LLY) from $145 to $165. Eli Lilly shares closed at $131.52 on Friday.
  • Raymond James boosted TCF Financial Corp (NASDAQ: TCF) price target from $53 to $58. TCF Financial shares closed at $46.67 on Friday.
  • HC Wainwright & Co. cut the price target on Abeona Therapeutics Inc (NASDAQ: ABEO) from $15 to $11. Abeona Therapeutics closed at $3.42 on Friday.
  • Mizuho boosted the price target on Fate Therapeutics Inc (NASDAQ: FATE) from $27 to $33. Fate Therapeutics closed at $19.74 on Friday.
  • B. Riley FBR lowered the price target for Anixa Biosciences Inc (NASDAQ: ANIX) from $11.25 to $8. Anixa Biosciences shares closed at $2.89 on Friday.
  • Citigroup boosted the price target for Zai Lab Ltd (NASDAQ: ZLAB) from $65 to $84. Zai Lab shares closed at $40.25 on Friday.
  • PiperJaffray lifted Bausch Health Companies Inc (NYSE: BHC) price target from $30 to $39. Bausch Health closed at $29.70 on Friday.
  • Cowen & Co. lifted the price target for Tesla Inc (NASDAQ: TSLA) from $190 to $210. Tesla shares closed at $430.38 on Friday.
  • BTIG boosted Stryker Corporation (NYSE: SYK) price target from $228 to $236. Stryker shares closed at $210.55 on Friday.
  • Cowen & Co. raised the price target for Boston Scientific Corporation (NYSE: BSX) from $47 to $52. Boston Scientific shares closed at $45.22 on Friday.

Posted-In: Price Target ChangesPrice Target Pre-Market Outlook Analyst Ratings

1 COMMENT

Subscribe
Notify of
1 Comment
Inline Feedbacks
View all comments

Stay Connected

157,359FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

Load more

Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Contact us: support@philstockworld.com

© Copyright - PSW, LLC.

2024
1
0
Would love your thoughts, please comment.x
()
x